Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve
NCT ID: NCT01514162
Last Updated: 2019-02-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
245 participants
INTERVENTIONAL
2012-02-29
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trifecta™ Long Term Follow-Up (LTFU) Study
NCT01593917
Trifecta™ GT Post Market Clinical Follow-up
NCT03016169
Aortic Valve Replacement With Trifecta(TM)
NCT00475709
An Observational, Prospective Evaluation of the Trifecta™ Valve
NCT00727181
Aortic Valve Replacement With Trifecta(TM)
NCT00475267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Trifecta Valve Group
Subjects implanted with a Trifecta valve.
Trifecta valve
surgical replacement of aortic valve
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Trifecta valve
surgical replacement of aortic valve
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject met eligibility criteria of IDE study
* Subject agrees to complete study follow-up visits
* Subject provides written informed consent
Exclusion Criteria
* Subject unable or unwilling to return for study follow-up visits
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abbott Northwestern Hospital Cardiac Surgical Associates
Minneapolis, Minnesota, United States
Mayo Clinic
Rochester, Minnesota, United States
Mission Hospital
Asheville, North Carolina, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Vanderbilt Heart Institute
Nashville, Tennessee, United States
Intermountain Heart & Lung Surgical Associates
Murray, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.